Similar Papers

Paper Title
Journal
Date
Author
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
...
Annals of Oncology | VOL. 31
, et. al. ...
25 Apr 2020
Efficacy and safety of avelumab plus axitinib in elderly patients with advanced renal cell carcinoma: extended follow-up results from JAVELIN Renal 101
Y Tomita ... M Schmidinger
ESMO Open | VOL. 7
Y Tomita, et. al.Y Tomita ... M Schmidinger
01 Apr 2022
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma
T Powles ... G De Velasco
Annals of Oncology | VOL. 32
T Powles, et. al.T Powles ... G De Velasco
28 Sep 2021
Efficacy of avelumab plus axitinib versus sunitinib by numbers of IMDC risk factors and target tumor sites at baseline in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101
Y Tomita ... M Schmidinger
ESMO Open | VOL. 8
Y Tomita, et. al.Y Tomita ... M Schmidinger
20 Oct 2023
View more papers

More From: BMJ Oncology

Paper Title
Journal
Date
Author
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
Alberto A Gabizon ... Ninh M La-Beck
BMJ Oncology | VOL. 4
Alberto A Gabizon, et. al.Alberto A Gabizon ... Ninh M La-Beck
09 Jan 2025
Advancing cancer care through digital access in the USA: a state-of-the-art review of patient portals in oncology
Uday Suresh ... Bryan Steitz
BMJ Oncology | VOL. 4
Uday Suresh, et. al.Uday Suresh ... Bryan Steitz
01 Jan 2025
Six-year performance of risk-based selection for lung cancer screening in the Manchester Lung Health Check cohort
Patrick Goodley ... Philip A J Crosbie
BMJ Oncology | VOL. 3
Patrick Goodley, et. al.Patrick Goodley ... Philip A J Crosbie
01 Dec 2024
Sintilimab plus bevacizumab followed by resection in intermediate-stage hepatocellular carcinoma: a phase Ib clinical trial with biomarker analysis
Hui-Chuan Sun ... Jia Fan
BMJ Oncology | VOL. 3
Hui-Chuan Sun, et. al.Hui-Chuan Sun ... Jia Fan
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.